I am in touch with a veteran reporter who has written about the pandemic. He seems intrigued that there has been no media coverage of Brilacidin. Does anyone have any theories about why that is happening? I don't see Leo out there bragging about B and K perhaps for fear of another frivolous lawsuit. The virologists working in the trials likely are not allowed to go public except in peer reviewed papers. I have a detailed history of the company from Polymedix days I can send him today. For obvious reasons I won't put his name on this board. Just private message me and I will send you his bio.
Time to rock and roll!